MR Spectroscopy and Spectroscopic Imaging of the Brain

Methods in Molecular Biology

Volumn 711, Issue , 2011, Pages 203-226

  Zhu, He ^a   Barker, Peter B ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Brain; magnetic resonance spectroscopy; metabolites; spatial localization; spectroscopic imaging

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN METABOLISM; DATA ANALYSIS; HUMAN; MEDICAL PRACTICE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRECLINICAL STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; TOUCH; BRAIN; CHEMISTRY; HISTOLOGY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ANIMALIA;

LIPID; PROTON; WATER;

BRAIN; HUMANS; LIPIDS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS; WATER;

EID: 79955643839     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-992-5_9     Document Type: Chapter

References (109)

1. Cady, E. B., Costello, A. M., Dawson, M. J., Delpy, D. T., Hope, P. L., Reynolds, E. O., Tofts, P. S., Wilkie, D. R. Noninvasive investigation of cerebral metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. Lancet 1983;1(8333):1059–1062.
2. Bottomley, P. A., Edelstein, W. A., Foster, T. H., Adams, W. A. In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: A window to metabolism? Proc Natl Acad Sci USA 1985;82(7):2148–2152.
3. Barker, P. B., Lin, D. D. In vivo proton MR spectroscopy of the human brain. Prog NMR Spect 2006;49:99–128.
4. Goldman, M., Johannesson, H., Axelsson, O., Karlsson, M. Hyperpolarization of 13C through order transfer from parahydrogen: A new contrast agent for MRI. Magn Reson Imaging 2005;23(2):153–157.
5. Barker, P. B., Gillard, J. H., van Zijl, P. C., Soher, B. J., Hanley, D. F., Agildere, A. M., Oppenheimer, S. M., Bryan, R. N. Acute stroke: Evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192(3):723–732.
6. Remy, C., Grand, S., Lai, E. S., Belle, V., Hoffmann, D., Berger, F., Esteve, F., Ziegler, A., Le Bas, J. F., Benabid, A. L., Decorps, M., Segebarth, C. M. 1H MRS of human brain abscesses in vivo and in vitro. Magn Reson Med 1995;34(4):508–514.
7. Lin, D. D., Crawford, T. O., Barker, P. B. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 2003;24(1):33–41.
8. Govindaraju, V., Young, K., Maudsley, A. A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000;13(3):129–153.
9. Frahm, J., Michaelis, T., Merboldt, K. D., Hanicke, W., Gyngell, M. L., Bruhn, H. On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed 1991;4(4): 201–204.
10. Pouwels, P. J., Frahm, J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997;10(2):73–78.
11. Barker, P. B. N-acetyl aspartate – a neuronal marker? Ann Neurol 2001;49(4):423–424.
12. Simmons, M. L., Frondoza, C. G., Coyle, J. T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45(1):37–45.
13. Bhakoo, K. K., Pearce, D. In vitro expression of N-acetyl aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000;74(1):254–262.
14. Burlina, A. P., Ferrari, V., Facci, L., Skaper, S. D., Burlina, A. B. Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate. J Neurochem 1997;69(3): 1314–1317.
15. Urenjak, J., Williams, S. R., Gadian, D. G., Noble, M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992;59(1):55–61.
16. Barker, P., Breiter, S., Soher, B., Chatham, J., Forder, J., Samphilipo, M., Magee, C., Anderson, J. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 1994;32: 157–163.
17. Gill, S. S., Small, R. K., Thomas, D. G., Patel, P., Porteous, R., van Bruggen, N., Gadian, D. G., Kauppinen, R. A., Williams, S. R. Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2(5–6):196–200.
18. Gill, S. S., Thomas, D. G., Van, B. N., Gadian, D. G., Peden, C. J., Bell, J. D., Cox, I. J., Menon, D. K., Iles, R. A., Bryant, D. J. Proton MR spectroscopy of intracranial tumours: In vivo and in vitro studies. J Comput Assist Tomogr 1990;14(4):497–504.
19. Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., McDonald, W. I. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993;341(8845):630–631.
20. Brenner, R. E., Munro, P. M., Williams, S. C., Bell, J. D., Barker, G. J., Hawkins, C. P., Landon, D. N., McDonald, W. I. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29(6):737–745.
21. Kreis, R., Ross, B. D., Farrow, N. A., Ackerman, Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182(1):19–27.
22. Stoll, A. L., Renshaw, P. F., De Micheli, E., Wurtman, R., Pillay, S. S., Cohen, B. M. Choline ingestion increases the resonance of choline-containing compounds in human brain: An in vivo proton magnetic resonance study. Biol Psychiatry 1995;37(3):170–174.
23. Urenjak, J., Williams, S. R., Gadian, D. G., Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989.
24. Jacobs, M. A., Horska, A., van Zijl, P. C., Barker, P. B. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med 2001;46(4):699–705.
25. Penrice, J., Cady, E. B., Lorek, A., Wylezinska, M., Amess, P. N., Aldridge, R. F., Stewart, A., Wyatt, J. S., Reynolds, E. O. Proton magnetic resonance spectroscopy of the brain in normal preterm and term infants, and early changes after perinatal hypoxia-ischemia. Pediatr Res 1996;40(1):6–14.
26. Petroff, O. A., Graham, G. D., Blamire, A. M., al-Rayess, M., Rothman, D. L., Fayad, P. B., Brass, L. M., Shulman, R. G., Prichard, J. W. Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes. Neurology 1992;42(7): 1349–1354.
27. Alger, J. R., Frank, J. A., Bizzi, A., Fulham, M. J., DeSouza, B. X., Duhaney, M. O., Inscoe, S. W., Black, J. L., van Zijl, P. C., Moonen, C. T. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177(3):633–641.
28. Mathews, P. M., Andermann, F., Silver, K., Karpati, G., Arnold, D. L. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43(12):2484–2490.
29. Brand, A., Richter-Landsberg, C., Leibfritz, D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15(3–5):289–298.
30. Flogel, U., Willker, W., Leibfritz, D. Regulation of intracellular pH in neuronal and glial tumour cells, studied by multinuclear NMR spectroscopy. NMR Biomed 1994;7(4): 157–166.
31. Ross, B. D., Michaelis, T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191–247.
32. Shonk, T. K., Moats, R. A., Gifford, P., Michaelis, T., Mandigo, J. C., Izumi, J., Ross, B. D. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 1995;195(1):65–72.
33. Kruse, B., Hanefeld, F., Christen, H. J., Bruhn, H., Michaelis, T., Hanicke, W., Frahm, J. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 1993;241(2): 68–74.
34. Magistretti, P. J., Pellerin, L., Rothman, D. L., Shulman, R. G. Energy on demand. Science 1999;283(5401):496–497.
35. Tkac, I., Andersen, P., Adriany, G., Merkle, H., Ugurbil, K., Gruetter, R. In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med 2001;46(3):451–456.
36. Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., Pelletier, D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005;128(Pt 5):1016–1025.
37. Kreis, R., Pfenninger, J., Herschkowitz, N., Boesch, C. In vivo proton magnetic resonance spectroscopy in a case of Reye’s syndrome. Intensive Care Med 1995;21(3): 266–269.
38. van Zijl, P. C. M., Barker, P. B. Magnetic Resonance Spectroscopy and Spectroscopic Imaging for the Study of Brain Metabolism. Imaging Brain Structure and Function, Vol. 820. New York, NY: Annals of the New York Academy of Sciences; 1997, pp 75–96.
39. Rothman, D. L., Petroff, O. A., Behar, K. L., Mattson, R. H. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993;90(12):5662–5666.
40. Terpstra, M., Henry, P. G., Gruetter, R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003;50(1):19–23.
41. Pan, J. W., Telang, F. W., Lee, J. H., de Graaf, R. A., Rothman, D. L., Stein, D. T., Hetherington, H. P. Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 2001;79(3): 539–544.
42. Seymour, K. J., Bluml, S., Sutherling, J., Sutherling, W., Ross, B. D. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma 1999;8(1):33–42.
43. Kreis, R., Pietz, J., Penzien, J., Herschkowitz, N., Boesch, C. Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic- resonance spectroscopy. J Magn Reson B 1995;107(3):242–251.
44. van der Knaap, M. S., Wevers, R. A., Struys, E. A., Verhoeven, N. M., Pouwels, P. J., Engelke, U. F., Feikema, W., Valk, J., Jakobs, C. Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 1999;46(6):925–928.
45. Cady, E. B., Lorek, A., Penrice, J., Reynolds, E. O., Iles, R. A., Burns, S. P., Coutts, G. A., Cowan, F. M. Detection of propan-1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med 1994;32(6):764–767.
46. Hanstock, C. C., Rothman, D. L., Shulman, R. G., Novotny, E. J., Jr., Petroff, O. A., Prichard, J. W. Measurement of ethanol in the human brain using NMR spectroscopy. J Stud Alcohol 1990;51(2):104–107.
47. Rose, S. E., Chalk, J. B., Galloway, G. J., Doddrell, D. M. Detection of dimethyl sul-fone in the human brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Imaging 2000;18(1):95–98.
48. Vermathen, P., Capizzano, A. A., Maudsley, A. A. Administration and (1)H MRS detection of histidine in human brain: Application to in vivo pH measurement. Magn Reson Med 2000;43(5):665–675.
49. Rothman, D. L., Behar, K. L., Prichard, J. W., Petroff, O. A. Homocarnosine and the measurement of neuronal pH in patients with epilepsy. Magn Reson Med 1997;38(6): 924–929.
50. Mori, S., Eleff, S. M., Pilatus, U., Mori, N., van Zijl, P. C. Proton NMR spectroscopy of solvent-saturable resonances: A new approach to study pH effects in situ. Magn Reson Med 1998;40(1):36–42.
51. Frahm, J. Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987;72(3):502–508.
52. van Zijl, P. C., Moonen, C. T., Alger, J. R., Cohen, J. S., Chesnick, S. A. High field localized proton spectroscopy in small volumes: Greatly improved localization and shimming using shielded strong gradients. Magn Reson Med 1989;10(2):256–265.
53. Duyn, J. H., Gillen, J., Sobering, G., van Zijl, P. C., Moonen, C. T. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188(1):277–282.
54. Ordidge, R. J. Random noise selective excitation pulses. Magn Reson Med 1987;5(1): 93–98.
55. Moonen, C. T. W., Sobering, G., van Zijl, P. C. M., Gillen, J., von Kienlin, M., Bizzi, A. Proton spectroscopic imaging of human brain. J Magn Reson 1992;98(3):556–575.
56. Moonen, C. T., von Kienlin, M., van Zijl, P. C., Cohen, J., Gillen, J., Daly, P., Wolf, G. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989;2(5–6):201–208.
57. Tkac, I., Starcuk, Z., Choi, I. Y., Gruetter, R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999;41(4):649–656.
58. Collins, C. M., Liu, W., Schreiber, W., Yang, Q. X., Smith, M. B. Central brightening due to constructive interference with, without, and despite dielectric resonance. J Magn Reson Imaging 2005;21(2):192–196.
59. Slotboom, J., Mehlkopf, A. F., Bovee, W. M. M. J. A single-shot localization pulse sequence suited for coils with inhomogeneous RF fields using adiabatic slice-selective RF pulses. J Magn Reson 1991;95:396–404.
60. Garwood, M., DelaBarre, L. The return of the frequency sweep: Designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153(2):155–177.
61. Scheenen, T. W., Heerschap, A., Klomp, D. W. Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses. Magma 2008;21(1–2):95–101.
62. Scheenen, T. W., Klomp, D. W., Wijnen, J. P., Heerschap, A. Short echo time 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn Reson Med 2008;59(1):1–6.
63. Hwang, T.-L., Shaka, A. J. Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients. J Magn Reson Ser A 1995;112: 275–279.
64. Levitt, M. H., Freeman, R. Compensation for pulse imperfections in NMR spin echo experiments. J Magn Reson 1981;43:65–80.
65. Mekle, R., Mlynarik, V., Gambarota, G., Hergt, M., Krueger, G., Gruetter, R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 2009;61(6):1279–1285.
66. Ordidge, R. J., Connelly, A., Lohman, J. A. B. Image-selected in vivo spectroscopy (ISIS) – a new technique for spatially selective NMR-spectroscopy. J Magn Reson 1986;66(2):283–294.
67. Ernst, R. R., Bodenhausen, G., Wokaun, A. Principles of Nuclear Magnetic Resonance in One and Two Dimensions. New York, NY: Oxford University Press; 1990, 640 p.
68. Golay, X., Gillen, J., van Zijl, P. C., Barker, P. B. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 2002;47(2):384–387.
69. Pohmann, R., von Kienlin, M., Haase, A. Theoretical evaluation and comparison of fast chemical shift imaging methods. J Magn Reson 1997;129(2):145–160.
70. Duyn, J. H., Moonen, C. T. Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med 1993;30(4):409–414.
71. Martin, A. J., Liu, H., Hall, W. A., Truwit, C. L. Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. AJNR Am J Neuroradiol 2001;22(5): 959–968.
72. Mansfield, P. Spatial mapping of chemical shift in NMR. Magn Reson Med 1984;1: 370–386.
73. Posse, S., Tedeschi, G., Risinger, R., Ogg, R., Le Bihan, D. High speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995;33(1):34–40.
74. Posse, S., DeCarli, C., Le Bihan, D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology 1994;192(3):733–738.
75. Ebel, A., Soher, B. J., Maudsley, A. A. Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis. Magn Reson Med 2001;46(6): 1072–1078.
76. Ebel, A., Maudsley, A. A., Weiner, M. W., Schuff, N. Achieving sufficient spectral bandwidth for volumetric 1H echo-planar spectroscopic imaging at 4 Tesla. Magn Reson Med 2005;54(3):697–701.
77. Pelletier, D., Nelson, S. J., Grenier, D., Lu, Y., Genain, C., Goodkin, D. E. 3-D echo planar (1)HMRS imaging in MS: Metabolite comparison from supratentorial vs. central brain. Magn Reson Imaging 2002;20(8):599–606.
78. Govindaraju, V., Gauger, G. E., Manley, G. T., Ebel, A., Meeker, M., Maudsley, A. A. Volumetric proton spectroscopic imaging of mild traumatic brain injury. AJNR Am J Neuroradiol 2004;25(5):730–737.
79. Adalsteinsson, E., Irarrazabal, P., Topp, S., Meyer, C., Macovski, A., Spielman, D. M. Volumetric spectroscopic imaging with spiral-based K-space trajectories. Magn Reson Med 1998;39(6):889–898.
80. Block, K. T., Frahm, J. Spiral imaging: A critical appraisal. J Magn Reson Imaging 2005;21(6):657–668.
81. Adalsteinsson, E., Star-Lack, J., Meyer, C. H., Spielman, D. M. Reduced spatial side lobes in chemical-shift imaging. Magn Reson Med 1999;42(2):314–323.
82. Sarkar, S., Heberlein, K., Hu, X. Truncation artifact reduction in spectroscopic imaging using a dual-density spiral K-space trajectory. Magn Reson Imaging 2002;20(10): 743–757.
83. Kim, D. H., Adalsteinsson, E., Spielman, D. M. Spiral readout gradients for the reduction of motion artifacts in chemical shift imaging. Magn Reson Med 2004;51(3):458–463.
84. Adalsteinsson, E., Langer-Gould, A., Homer, R. J., Rao, A., Sullivan, E. V., Lima, C. A., Pfefferbaum, A., Atlas, S. W. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2003;24(10):1941–1945.
85. Pruessmann, K. P., Weiger, M., Scheideg-ger, M. B., Boesiger, P. SENSE: Sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952–962.
86. Sodickson, D. K., Manning, W. J. Simultaneous acquisition of spatial harmonics (SMASH): Fast imaging with radiofrequency coil arrays. Magn Reson Med 1997;38(4):591–603.
87. Jakob, P. M., Griswold, M. A., Edelman, R. R., Sodickson, D. K. AUTO-SMASH: A self-calibrating technique for SMASH imaging. Simultaneous acquisition of spatial harmonics. Magma 1998;7(1):42–54.
88. McKenzie, C. A., Yeh, E. N., Ohliger, M. A., Price, M. D., Sodickson, D. K. Self-calibrating parallel imaging with automatic coil sensitivity extraction. Magn Reson Med 2002;47(3):529–538.
89. Griswold, M. A., Jakob, P. M., Heidemann, R. M., Nittka, M., Jellus, V., Wang, J., Kiefer, B., Haase, A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47(6):1202–1210.
90. Dydak, U., Weiger, M., Pruessmann, K. P., Meier, D., Boesiger, P. Sensitivity-encoded spectroscopic imaging. Magn Reson Med 2001;46(4):713–722.
91. Tsai, S. Y., Otazo, R., Posse, S., Lin, Y. R., Chung, H. W., Wald, L. L., Wiggins, G. C., Lin, F. H. Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32-channel phased-array coil. Magn Reson Med 2008;59(5):989–998.
92. Dydak, U., Pruessmann, K. P., Weiger, M., Tsao, J., Meier, D., Boesiger, P. Parallel spectroscopic imaging with spin-echo trains. Magn Reson Med 2003;50(1):196–200.
93. Lin, F. H., Tsai, S. Y., Otazo, R., Caprihan, A., Wald, L. L., Belliveau, J. W., Posse, S. Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain. Magn Reson Med 2007;57(2):249–257.
94. Smith, M. A., Gillen, J., McMahon, M. T., Barker, P. B., Golay, X. Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med 2005;54(3):691–696.
95. Dreher, W., Leibfritz, D. Detection of homonuclear decoupled in vivo proton NMR spectra using constant time chemical shift encoding: CT-PRESS. Magn Reson Imaging 1999;17(1):141–150.
96. 1 H NMR chemical shift selective imaging. Phys Med Biol 1985;30(4):341–344.
97. Moonen, C. T. W., van Zijl, P. C. M. Highly efficient water suppression for in vivo proton NMR spectroscopy. J Magn Reson 1990;88:28–41.
98. Ogg, R. J. WET a T1-and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1–10.
99. Mescher, M., Merkle, H., Kirsch, J., Garwood, M., Gruetter, R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998;11(6):266–272.
100. Star-Lack, J., Nelson, S. J., Kurhanewicz, J., Huang, L. R., Vigneron, D. B. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997;38(2):311–321.
101. Spielman, D. M., Pauly, J. M., Macovski, A., Glover, G. H., Enzmann, D. R. Lipid-suppressed single-and multisection proton spectroscopic imaging of the human brain. J Magn Reson Imaging 1992;2(3):253–262.
102. Gu, M., Spielman, D. M. B1 and T1 insensitive water and lipid suppression using optimized multiple frequency-selective preparation pulses for whole-brain 1H spectroscopic imaging at 3T. Magn Reson Med 2009;61(2):462–466.
103. Zhu, H., Ouwerkerk, R., Barker, P. B. Dual band water and lipid suppression for MR spectroscopic imaging at 3 Tesla. Magn Reson Med 2009;(accepted for publication).
104. Kelley, D. A., Wald, L. L., Star-Lack, J. M. Lactate detection at 3T: Compensating J coupling effects with BASING. J Magn Reson Imaging 1999;9(5):732–737.
105. Raphael, C. In vivo NMR spectral parameter estimation: A comparison between time and frequency domain methods. Magn Reson Med 1991;18:358–370.
106. de Beer, R., van den Boogaart, A., van Ormondt, D., Pijnappel, W. W., den Hollander, J. A., Marien, A. J., Luyten, P. R. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 1992;5(4): 171–178.
107. Provencher, S. W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30(6):672–679.
108. Henriksen, O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995;8(4):139–148.
109. Soher, B. J., van Zijl, P. C., Duyn, J. H., Barker, P. B. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996;35(3): 356–363.